Suchergebnisse - "Stolbach, Andrew I."

PubPharm (74)

1

ACMT Comment on Recent Guidance on PFAS Laboratory Testing

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2024

von Downs, J. | Nacca, N. | Stolbach, A. | +1

2

Ensuring the Efficacy and Safety of Approved Medications

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2024

von Mazer-Amirshahi, M. | Cole, J. | Stolbach, A. | +2

3

Ensuring the Efficacy and Safety of Approved Medications

enthalten in: Journal of medical toxicology | 2024

von Mazer-Amirshahi, M. | Cole, J. | Stolbach, A. | +2

4

Correction : American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2024

von Stolbach, A. | Mazer-Amirshahi, M. | Nelson, L. | +1

ErratumFor: J Med Toxicol. 2024 Jan;20(1):64-67. - PMID 38032431

5

American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement : Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2024

von Stolbach, A. | Mazer-Amirshahi, M. | Nelson, L. | +1

ErratumIn: J Med Toxicol. 2023 Dec 28;:. - PMID 38153673

6

Correction: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

enthalten in: Journal of medical toxicology | 2023

von Stolbach, A. | Mazer‑Amirshahi, M. | Nelson, L. | +1

7

American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

enthalten in: Journal of medical toxicology | 2023

von Stolbach, A. | Mazer-Amirshahi, M. | Nelson, L. | +1

8

American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement : nalmefene should not replace naloxone as the primary opioid antidote at this time

enthalten in: Clinical toxicology (Philadelphia, Pa.) | 2023

von Stolbach, A. | Mazer-Amirshahi, M. | Nelson, L. | +1

ErratumIn: Clin Toxicol (Phila). 2023 Nov;61(11):1012. - PMID 38112313

9

ACMT Position Statement : Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2023

von Mazer-Amirshahi, M. | Stolbach, A. | Ye, P.

10

ACMT Position Statement : Role of the Medical Toxicologist in the Management of Patients with Substance Use Disorder

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2023

von Stolbach, A. | Mazer-Amirshahi, M. | Cienki, J. | +6

1
2
3
4
5
6
7
8
Nächster »
[8]